>Mercado de frascos farmacêuticos da América do Norte, por material (vidro, plástico e outros), tipo de pescoço (pescoço de parafuso, pescoço de cravação, câmara dupla, tampa articulada e outros), tamanho da tampa (13-425 mm, 15 -425 mm, 18-400 mm, 22-350 mm, 24-400 mm, 8-425 mm, 9mm e Outros), Canal de Distribuição (Vendas Diretas, Lojas Médicas/Farmácias, E-Commerce e Outros), Capacidade ( 1 ml,2 ml, 3 ml , 4 ml, 8 ml, 10 ml, 20 ml, 30 ml, 50 ml e outros), Tipo de medicamento (injetável e não injetável), aplicação (oral, nasal, injetável e outros) , utilizador final (empresas farmacêuticas, Empresas biofarmacêuticas, empresas de desenvolvimento e fabrico de contratos, farmácias compostas e outras), mercado (parenteral, gastro, otorrinolaringológico e outros), país (EUA, Canadá e México), tendências e previsões da indústria para 2028
Análise e insights de mercado: Mercado de frascos farmacêuticos da América do Norte
Espera-se que o mercado de frascos farmacêuticos ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 6,9% no período de previsão de 2021 a 2028 e deverá atingir os US$ 9.007,39 milhões até 2028.
Os frascos farmacêuticos são o tipo de pequenos recipientes de plástico, vidro ou plástico que são utilizados no armazenamento de medicamentos, que são utilizados principalmente no armazenamento de líquidos e, por vezes, para líquidos, sob a forma de cápsulas. Os frascos farmacêuticos estão presentes em diversas áreas como empresas farmacêuticas, empresas biofarmacêuticas, farmácias de manipulação e em vários outros locais. Os frascos farmacêuticos são fabricados a partir de diversos materiais como plástico , vidro e diversos outros. Os frascos ajudam a proporcionar uma vida útil e durabilidade aos produtos.
Vários fabricantes estão envolvidos na produção de produtos de embalagem de alta qualidade em material de vidro e plástico, o que pode ajudar a aumentar a vida útil dos produtos farmacêuticos. Os produtos de embalagem com design multicamada na indústria farmacêutica oferecem uma garantia de integridade adicional, mesmo sob impacto forçado. Para a embalagem de soluções medicamentosas tóxicas ou de alta potência, a procura de produtos combinados de resistência a fissuras e desempenho de integridade está a aumentar na indústria farmacêutica.
Este relatório de mercado de frascos farmacêuticos fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um Analyst Brief, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.
Âmbito do mercado de frascos farmacêuticos da América do Norte e dimensão do mercado
North America pharmaceutical vials market is segmented of the basis into material, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of material, the pharmaceutical vials market is segmented into plastic, glass and others. In 2021, glass is dominating because of the non-leakage properties which are driving pharmaceutical vials market.
- On the basis of neck type, the pharmaceutical vials market is segmented into crimp neck, double chamber, screw neck, flip cap and others. In 2021, Screw neck segment is dominating because of growing application in gastro sector.
- On the basis of cap size, the market is segmented into 13-425 MM, 15-425 MM, 18-400 MM, 22-350 MM, 24-400 MM, 8-425 MM, 9MM and others. In 2021, 9MM is dominating because the processing takes place at large scale due to requirement.
- On the basis of distribution channel, the market is segmented into direct sales, medical stores/pharmacies, e-commerce and others. In 2021, direct sales are dominating because of the huge build relationships with the customers which boost the demand of the pharmaceutical vials market.
- On the basis of capacity, the market is segmented into 1 ML, 2 ML, 3 ML, 4 ML, 8 ML, 10 ML, 20 ML, 30 ML, 50 ML and others. In 2021, 1 ML is dominating because of high efficiency which boosts the demand of the pharmaceutical vials market.
- On the basis of drug type, the market is segmented into injectable and non-injectable. In 2021, Injectable is dominating because of properties which control the dosage consumption amount that maximizes its application.
- On the basis of application, the market is segmented into nasal, oral and others. In 2021, Oral is dominating because of the huge amount of consumption in biopharmaceutical companies.
- On the basis of end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy and others. In 2021, pharmaceutical companies are dominating because of increasing formation of medicines to treat various diseases that is the reason which boosts the demand of the pharmaceutical vials market.
- On the basis of market, the pharmaceutical vials market is segmented into parenteral, gastro, ENT and others. In 2021, the parenteral segment is dominating because of the features that enhances medication adherence.
Pharmaceutical vials Market Country Level Analysis
North America pharmaceutical vials market is analysed and market size information is provided by material, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market.
The countries covered in the pharmaceutical vials market report are U.S., Canada and Mexico in North America.
North America pharmaceutical vials market is dominating the market due to growing demand of packaging in pharmaceutical industry in the region. The U.S. is dominating in the pharmaceutical vials market as pharmaceutical vials products are highly manufactured and consumed in the country. Also, high innovations and development in the manufacturing of products is one of the major factors for the growth of the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growth in the Pharmaceutical Vials Industry
North America pharmaceutical vials market also provides you with detailed market analysis for every country growth in installed base of different kind of products for pharmaceutical vials market, impact of technology using life line curves and changes in infant formula regulatory scenarios and their impact on the pharmaceutical vials market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Pharmaceutical Vials Market Share Analysis
North America pharmaceutical vials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to North America pharmaceutical vials market.
The major players covered in the report are Gerresheimer AG, SCHOTT AG , Berry Global Inc., West Pharmaceutical Services Inc, Origin Pharma Packaging, SGD Pharma, Pacific Vial Manufacturing Inc., Bormioli Pharma S.p.a, TOYOBO CO., LTD., NIPRO, Piramal Glass Private Limited, Corning Incorporated, DWK Life Sciences Ltd, APG and Stevanato Group, among other players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
- In May 2020, Piramal Glass Private Limited. company have decided make development in the business with transformation of the glass packaging products to a digital glass manufacturer. This development helps the company to increase revenue..
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 DRUG TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 VENDOR SHARE ANALYSIS
2.13 IMPORT-EXPORT DATA
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING DEMAND OF PACKAGING IN PHARMACEUTICAL INDUSTRY
5.1.2 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING
5.1.3 GROWTH OF PREFILLED SYRINGES
5.1.4 GROWING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR STORAGE OF LIQUID MEDICINE
5.2 RESTRAINTS
5.2.1 CHEMICALS RELEASE OF THE INTERNAL SURFACE OF GLASS TUBING CONTAINERS
5.2.2 INCREASING COST OF OVERALL PACKAGING
5.3 OPPORTUNITIES
5.3.1 IMPLEMENTING READY-TO USE GLASS VIALS FOR FLEXIBLE ASEPTIC FILLING
5.3.2 INCREASING DEMAND OF PACKAGING FOR COVID-19 VACCINE
5.4 CHALLENGES
5.4.1 RECYCLING OF WASTE PRODUCE BY PHARMACEUTICAL PACKAGING
5.4.2 INCREASING GOVERNMENT REGULATIONS TOWARDS PHARMACEUTICAL SECTOR
6 COVID-19 IMPACT ON THE PHARMACEUTICAL VIALS MARKET IN CHEMICAL AND MATERIALS INDUSTRY
6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET
6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET
6.3 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
6.4 PRICE IMPACT
6.5 IMPACT ON DEMAND
6.6 IMPACT ON SUPPLY CHAIN
6.7 CONCLUSION
7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL
7.1 OVERVIEW
7.2 GLASS
7.2.1 GLASS BY COLOR
7.2.1.1 Amber
7.2.1.2 Clear
7.2.1.3 Others
7.2.2 GLASS BY TYPE
7.2.2.1 TYPE I (Borosilicate Glass)
7.2.2.2 TYPE II (Treated Soda-Lime Glass)
7.2.2.3 TYPE III (Regular Soda Lime Glass)
7.2.2.4 TYPE IV (Type Np Glass/General-Purpose Soda Lime Glass)
7.2.3 GLASS BY PRODUCT
7.2.3.1 Serum / Specialty Glass Vials
7.2.3.2 Screw Thread Glass Vials
7.2.3.3 Sterile Glass Vials
7.2.3.4 Sample Glass Vials
7.2.3.5 Autosampler Vials
7.2.3.6 Chromatography Vials
7.2.3.7 Epa Voa Vials
7.2.3.8 Others
7.3 PLASTIC
7.3.1 PLASTIC BY COLOR
7.3.1.1 Translucent
7.3.1.2 Opaque
7.3.1.3 Others
7.3.2 PLASTIC BY TYPE
7.3.2.1 High-density polyethylene (HDPE)
7.3.2.2 Polystyrene
7.3.2.3 Polypropylene
7.3.2.4 Polyvinyl Chloride (PVC)
7.3.2.5 Polycarbonate
7.3.2.6 Polyester
7.3.2.7 Others
7.4 OTHERS
8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE
8.1 OVERVIEW
8.2 SCREW NECK
8.3 CRIMP NECK
8.4 DOUBLE CHAMBER
8.5 FLIP CAP
8.6 OTHERS
9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE
9.1 OVERVIEW
9.2 9MM
9.3 8-425 MM
9.4 13-425 MM
9.5 15-425 MM
9.6 18-400 MM
9.7 22-350 MM
9.8 24-400 MM
9.9 OTHERS
10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT SALES
10.3 MEDICAL STORES/PHARMACIES
10.4 E-COMMERCE
10.5 OTHERS
11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY
11.1 OVERVIEW
11.2 1 ML
11.3 2 ML
11.4 3 ML
11.5 4 ML
11.6 8 ML
11.7 10 ML
11.8 20 ML
11.9 30 ML
11.1 50 ML
11.11 OTHERS
12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE
12.1 OVERVIEW
12.2 INJECTABLE
12.2.1 INJECTABLE TYPE
12.2.1.1 Lyophilized
12.2.1.2 Liquid
12.3 NON-INJECTABLE
12.3.1 NON-INJECTABLE TYPE
12.3.1.1 Diagnostic
12.3.1.2 Solid
13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 ORAL
13.3 NASAL
13.4 OTHERS
14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER
14.1 OVERVIEW
14.2 PHARMACEUTICAL COMPANIES
14.3 BIOPHARMACEUTICAL COMPANIES
14.4 CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES
14.5 COMPOUND PHARMACY
14.6 OTHERS
15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET
15.1 OVERVIEW
15.2 PARENTERAL
15.3 GASTRO
15.4 ENT
15.5 OTHERS
16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY GEOGRAPHY
16.1 OVERVIEW
16.2 NORTH AMERICA
16.2.1 U.S.
16.2.2 CANADA
16.2.3 MEXICO
17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17.2 MERGERS & ACQUISITIONS
17.3 EXPANSIONS
17.4 NEW PRODUCT DEVELOPMENT
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 BERRY NORTH AMERICA INC.
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT UPDATE
19.2 WEST PHARMACEUTICAL SERVICES, INC.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT UPDATE
19.3 PIRAMAL GLASS PRIVATE LIMITED (A SUBSIDIARY OF PIRAMAL ENTERPRISES LTD.)
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT UPDATE
19.4 TOYOBO CO., LTD.
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT UPDATE
19.5 CORNING INCORPORATED
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT UPDATES
19.6 GERRESHEIMER AG
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT UPDATE
19.7 NIPRO
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT UPDATE
19.8 SCHOTT AG
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT UPDATE
19.9 APG
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT UPDATE
19.1 BORMIOLI PHARMA S.P.A.
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT UPDATE
19.11 DWK LIFE SCIENCES LTD.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT UPDATE
19.12 ORIGIN PHARMA PACKAGING
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT UPDATE
19.13 PACIFIC VIAL
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT UPDATE
19.14 SGD PHARMA (A SUBSIDIARY OF SAINT-GOBAIN)
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT UPDATE
19.15 STEVANATO GROUP
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT UPDATE
20 QUESTIONNAIRE
21 RELATED REPORTS
Lista de Tabela
LIST OF TABLES
TABLE 1 IMPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 2 EXPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 3 TIME TAKEN FOR GARBAGE TO DECOMPOSE IN THE ENVIRONMENT (2015)
TABLE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY TYPE, 2019-2028 (MILLION UNITS)
TABLE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (MILLION UNITS)
TABLE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (MILLION UNITS)
TABLE 13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (MILLION UNITS)
TABLE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, SCREW NECK BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CRIMP NECK BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DOUBLE CHAMBER BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, FLIP CAP BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 9MM BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 13-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 15-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 18-400 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 22-350 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 24-400 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DIRECT SALES BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, MEDICAL STORES/PHARMACIES BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, E-COMMERCE BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 1 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 2 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 3 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 4 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 10 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 20 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 30 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 50 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, INJECTABLE BY REGION, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY INJECTABLE TYPE, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NON-INJECTABLE BY REGION, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NON-INJECTABLE TYPE, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ORAL BY REGION, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NASAL BY REGION, 2019-2028 (USD MILLION)
TABLE 56 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 57 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER, 2019-2028 (USD MILLION)
TABLE 58 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 59 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BIOPHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 60 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 61 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, COMPOUND PHARMACY BY REGION, 2019-2028 (USD MILLION)
TABLE 62 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 63 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET, 2019-2028 (USD MILLION)
TABLE 64 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PARENTERAL BY REGION, 2019-2028 (USD MILLION)
TABLE 65 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GASTRO BY REGION, 2019-2028 (USD MILLION)
TABLE 66 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ENT BY REGION, 2019-2028 (USD MILLION)
TABLE 67 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 69 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (MILLION UNITS)
TABLE 70 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 71 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (USD MILLION)
TABLE 72 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (MILLION UNITS)
TABLE 73 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 74 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 75 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 76 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 78 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 79 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 80 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 81 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 82 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 83 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 84 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 85 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 86 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 87 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 88 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 89 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 90 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 91 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 92 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 93 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 94 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 95 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 96 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 97 U.S. PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 98 U.S. PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 99 U.S. PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 100 U.S. PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 101 U.S. PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 102 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 103 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 104 U.S. PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 105 U.S. PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 106 U.S. PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 107 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 108 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 109 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 110 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 111 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 112 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 113 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 114 CANADA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 115 CANADA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 116 CANADA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 117 CANADA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 118 CANADA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 119 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 120 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 121 CANADA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 122 CANADA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 123 CANADA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 124 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 125 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 126 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 127 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 129 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 130 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 131 MEXICO PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 132 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 133 MEXICO PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 134 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 135 MEXICO PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 136 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 137 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 138 MEXICO PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 139 MEXICO PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 140 MEXICO PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
Lista de Figura
LIST OF FIGURES
FIGURE 1 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE DRUG TYPE LIFE LINE CURVE
FIGURE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION
FIGURE 12 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING IS DRIVING THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GLASS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR PHARMACEUTICAL VIALS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET
FIGURE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL, 2020
FIGURE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY NECK TYPE, 2020
FIGURE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAP SIZE, 2020
FIGURE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAPACITY, 2020
FIGURE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DRUG TYPE, 2020
FIGURE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY APPLICATION, 2020
FIGURE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY END-USER, 2020
FIGURE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MARKET, 2020
FIGURE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2019)
FIGURE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019)
FIGURE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2020 & 2027)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019 & 2027)
FIGURE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2020-2027)
FIGURE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2020)
FIGURE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020)
FIGURE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2021-2028)
FIGURE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
